Skip to main content
. 2022 Sep 29;13:998217. doi: 10.3389/fimmu.2022.998217

Figure 5.

Figure 5

(A) Network visualization of the institution co-citation analysis on targeted immunotherapy for MG based on the VOSviewer. (B) The top 10 funding agencies for the output of targeted immunotherapy for MG.